A new paradigm for classifying and treating HER2-positive breast cancer.

Xuexin He Sai-Ching Jim YeungFrancisco J Esteva

Published in: Cancer reports (Hoboken, N.J.) (2023)

It will assist clinicians in developing an optimal treatment regimen at the outset, curing more HER2+ BC patients and improving their quality of life.

Keyphrases

positive breast cancer
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
replacement therapy
smoking cessation